Sharma East India Hospitals & Medical Research Ltd

As of June 30, 2026, Sharma East India Hospitals & Medical Research Ltd carries a market capitalization of 340.07M, placing it among publicly traded companies globally. Its enterprise value stands at 340.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Sharma East India Hospitals & Medical Research Ltd has 3.29M shares outstanding.

As of June 30, 2026, Sharma East India Hospitals & Medical Research Ltd trades at a trailing price-to-earnings ratio of 28.62.

As of June 30, 2026, Sharma East India Hospitals & Medical Research Ltd trades at an EV/EBITDA multiple of 9.52 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.91 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 17.72 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 340.07M versus a market cap of 340.07M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Sharma East India Hospitals & Medical Research Ltd recorded 3.01M in income tax expense. That works out to an effective tax rate of 20.26, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 14.86M, leaving 11.85M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Sharma East India Hospitals & Medical Research Ltd's stock has declined approximately 40.39% over the past 52 weeks. The 50-day moving average sits at 90.34, while the 200-day moving average is 101.08.

Over the twelve months ended June 30, 2026, Sharma East India Hospitals & Medical Research Ltd generated 372.24M in revenue and converted that into 11.85M in net income, yielding earnings per share of 3.61. EBITDA reached 35.72M, while operating income came in at 19.19M.

Over the twelve months ended June 30, 2026, Sharma East India Hospitals & Medical Research Ltd posted a gross margin of 20.21, reflecting its pricing power and cost economics. The operating margin of 5.15 and net profit margin of 3.18 provide insight into operational efficiency.